Balyasny Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$348K Buy
+6,738
New +$343K ﹤0.01% 2506
2022
Q3
Sell
-23,643
Closed -$684K 3248
2022
Q2
$684K Sell
23,643
-123,826
-84% -$3.55M ﹤0.01% 1891
2022
Q1
$4.77M Buy
+147,469
New +$4.52M 0.02% 972
2020
Q3
Sell
-18,475
Closed -$439K 1586
2020
Q2
$439K Buy
18,475
+1,759
+11% +$38.9K ﹤0.01% 940
2020
Q1
$301K Sell
16,716
-604
-3% -$12.7K ﹤0.01% 991
2019
Q4
$411K Buy
+17,320
New +$421K ﹤0.01% 1026
2018
Q3
Sell
-4,024
Closed -$241K 2022
2018
Q2
$241K Sell
4,024
-1,375
-25% -$71.2K ﹤0.01% 1585
2018
Q1
$247K Buy
+5,399
New +$225K ﹤0.01% 1685
2017
Q4
Sell
-145,625
Closed -$5.83M 2299
2017
Q3
$5.83M Buy
145,625
+140,836
+2,941% +$6.09M 0.02% 662
2017
Q2
$206K Buy
+4,789
New +$170K ﹤0.01% 1377
2016
Q4
Sell
-110,847
Closed -$2.74M 1477
2016
Q3
$2.74M Buy
+110,847
New +$2.51M 0.02% 586

Other funds holding SUPN